Gelteq Limited Ordinary Shares (GELS) vs enVVeno Medical Corporation (NVNO)

A side-by-side comparison of Gelteq Limited Ordinary Shares and enVVeno Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Gelteq Limited Ordinary Shares logo
GELS
Gelteq Limited Ordinary Shares
$5M
$0.57HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
enVVeno Medical Corporation logo
NVNO
enVVeno Medical Corporation
$6M
$8.30HealthcareDelayed quote: Oct 6, 2026, 12:46 PM EDT

Total return — GELS vs NVNO

growth of $100 · dividends reinvested · last 2y
GELS -81.5% (-57.0%/yr)NVNO -93.5% (-74.4%/yr)GELS compounded faster over this window
050100150Start $10020252026$18$7
GELS NVNO

GELS vs NVNO: by the numbers

  • •NVNO is the larger company ($6M vs $5M market cap).
  • •Both run net losses; NVNO's is the smaller (0.00% vs -4011.86% net margin).

Metrics side by side

Valuation

MetricGELSNVNO
P/B ratio0.550.28

Profitability

MetricGELSNVNO
Gross margin100.00%0.00%
Operating margin-3317.65%0.00%
Net margin-4011.86%0.00%
ROE-42.05%-76.07%
ROIC-27.41%-80.65%

Growth (annualized)

MetricGELSNVNO
Total return CAGR (5Y)N/A-52.99%

Go deeper

Full GELS analysisFull NVNO analysisInteractive comparison tool

Dig into the metrics

Gelteq Limited Ordinary Shares ROEenVVeno Medical ROEGelteq Limited Ordinary Shares operating marginenVVeno Medical operating marginGelteq Limited Ordinary Shares revenue growthenVVeno Medical revenue growthGelteq Limited Ordinary Shares free cash flowenVVeno Medical free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.